These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25087292)

  • 1. Androgens and cardiac diseases.
    Bianchi V; Mezzani A
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):161-9. PubMed ID: 25087292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of androgens on lipids.
    Monroe AK; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and androgens: a review.
    Kaushik M; Sontineni SP; Hunter C
    Int J Cardiol; 2010 Jun; 142(1):8-14. PubMed ID: 19923015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and coronary artery disease.
    Schwarcz MD; Frishman WH
    Cardiol Rev; 2010; 18(5):251-7. PubMed ID: 20699673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and cardiovascular disease: gender-related differences.
    Spoletini I; Caprio M; Vitale C; Rosano GM
    Menopause Int; 2013 Jun; 19(2):82-6. PubMed ID: 23761317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism.
    Miller KK; Biller BM; Schaub A; Pulaski-Liebert K; Bradwin G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2474-9. PubMed ID: 17426086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and cardiovascular disease in women and men.
    Armeni E; Lambrinoudaki I
    Maturitas; 2017 Oct; 104():54-72. PubMed ID: 28923177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the safety of testosterone therapy in cardiac disease.
    Aaronson AJ; Morrissey RP; Nguyen CT; Willix R; Schwarz ER
    Expert Opin Drug Saf; 2011 Sep; 10(5):697-704. PubMed ID: 21417959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.
    Morgentaler A
    Urology; 2016 Mar; 89():27-32. PubMed ID: 26683750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China.
    Chen Q; Fu Z; Wu X; Jin L; Li J; Wang Y; Li X
    Aging Male; 2014 Sep; 17(3):155-60. PubMed ID: 24805790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trials of testosterone replacement reporting cardiovascular adverse events.
    Gagliano-Jucá T; Basaria S
    Asian J Androl; 2018; 20(2):131-137. PubMed ID: 28782738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens, cardiovascular disease and osteoporosis.
    Isidori AM; Giannetta E; Pozza C; Bonifacio V; Isidori A
    J Endocrinol Invest; 2005; 28(10 Suppl):73-9. PubMed ID: 16550728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone reducing cardiovascular risk--looks promising but randomised trials needed.
    Jackson G
    Int J Clin Pract; 2008 Aug; 62(8):1131-2. PubMed ID: 18705815
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone and cardiovascular risk.
    Tirabassi G; Gioia A; Giovannini L; Boscaro M; Corona G; Carpi A; Maggi M; Balercia G
    Intern Emerg Med; 2013 Apr; 8 Suppl 1():S65-9. PubMed ID: 23475207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is understanding the relationship of testosterone to cardiovascular risk so important?
    Yeap BB; Anawalt BD
    Asian J Androl; 2018; 20(2):107-108. PubMed ID: 29405170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.